Martina Canichella | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings	LEUKEMIA & LYMPHOMA	2022
Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemia	HEMATOLOGICAL ONCOLOGY	2021
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial	AMERICAN JOURNAL OF HEMATOLOGY	2021
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimale residual disease-oriented GIMEMA LAL1913	HAEMATOLOGICA	2020
Dasatinib-blinatumomab for ph-positive acute lymphoblastic leukemia in adults	NEW ENGLAND JOURNAL OF MEDICINE	2020
Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma	BRITISH JOURNAL OF HAEMATOLOGY	2019
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol	LEUKEMIA & LYMPHOMA	2019
Response to interferon-free direct antivirals (DAAS) treatment in Hcv-related subcutaneous marginal zone B-cell lymphoma with lipoma-like presentation: report of two cases	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2019
Long-term response to daratumumab in a patient with advanced immunoglobulin light-chain (AL) amyloidosis with organ damage	ANNALS OF HEMATOLOGY	2019
Nivolumab as a safe and effective treatment in an HIV patient with refractory Hodgkin lymphoma	ANNALS OF HEMATOLOGY	2019
Current and future therapeutic approaches for the treatment of follicular lymphoma	EXPERT REVIEW OF ANTICANCER THERAPY	2018
Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?	EUROPEAN JOURNAL OF HAEMATOLOGY	2018
Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors.	BRITISH JOURNAL OF HAEMATOLOGY	2017
The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials.	AMERICAN JOURNAL OF HEMATOLOGY	2017
The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials	AMERICAN JOURNAL OF HEMATOLOGY	2017
Very late relapse in a patient with acute promyelocytic leukemia (APL) rescued with a chemotherapy-free protocol	LEUKEMIA & LYMPHOMA	2016
A case of late isolated ovarian relapse of acute lymphoblastic leukemia after an allogeneic stem cell transplant.	LEUKEMIA & LYMPHOMA	2015